Significant coronary stenosis detected by coronary computed angiography in asymptomatic HIV infected subjects by Gabriella D'Ettorre et al.
Journal of Infection (2012) 64, 82e88www.elsevierhealth.com/journals/jinfSignificant coronary stenosis detected by coronary
computed angiography in asymptomatic HIV
infected subjectsGabriella d’Ettorre a, Marco Francone b, Massimo Mancone c,
Giancarlo Ceccarelli a, Adriano Ascarelli b, Francesco Vullo b,
Silvia Baroncelli d, M. Clementina Galluzzo d, Carlo Catalano b,
Stefano Strano a, Francesco Fedele c, Claudio Mastroianni a,
Lucia Palmisano d,*, Vincenzo Vullo aaDepartment of Public Health and Infectious Diseases, “Sapienza” University, Rome, Italy
bDepartment of Radiological Sciences, “Sapienza” University, Rome, Italy
cDepartment of Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, “Sapienza” University, Rome, Italy
d Istituto Superiore di Sanita, Department of Therapeutic Research and Medicines Evaluation, Viale Regina Elena 299,
00161 Rome, Italy
Accepted 27 September 2011
Available online 1 October 2011KEYWORDS
HIV;
Heart;
CT scan* Corresponding author. Tel.: þ39 0
E-mail addressess: l.palmisano@iss
0163-4453/$36 ª 2011 The British Inf
doi:10.1016/j.jinf.2011.09.007Summary Objectives: increased incidence of acute coronary events, high rate of abnormal
surrogate markers of atherosclerosis and increased amount of coronary calcium have been de-
scribed in HIV infected population.
To expand knowledge on coronary artery disease (CAD) in HIV patients, cardiac CT scan was
performed in asymptomatic subjects with low cardiovascular (CV) risk.
Methods: A cross-sectional study using dual-source CT (MDCT) coronary angiography.was con-
ducted in HIV-infected subjects with the following characteristics: Framingham Risk Score
(FRS) 10, absence of metabolic syndrome, negative echocardiographic and ECG stress-test.
A luminal narrowing exceeding 50% was defined as a clinically significant coronary stenosis.
Calcium score was quantified using the Agatston Calcium Score method.
Results: Fifty-five subjects were enrolled. Significant coronary stenoses, requiring coronary
angiography, were found in 16/55 (29.1%). At multivariate analysis older age was the only
variable independently associated with the presence of significant luminal narrowing
(p Z 0.011).6 49384021; fax: þ39 06 49387199.
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ection Association. Published by Elsevier Ltd. All rights reserved.
Coronary artery disease in HIV infected subjects 83Conclusions: MDCT showed an unexpected, age-associated high rate of significant coronary
stenosis in asymptomatic HIV positive subjects with low CV risk. These findings suggest that
aggressive screening programs for coronary artery disease may be appropriate in this popula-
tion; further studies are recommended to assess the appropriateness of MDCT for this pur-
pose.
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In the last few years increased cardiovascular morbidity and
mortality has been reported in subjects with HIV infection,1
even in countries where the rate of this complication is rela-
tively low.2 Commonly used tools to evaluate cardiovascular
risk, such as the Framingham Risk Score (FRS), are inade-
quate in HIVþ subjects,3 in fact, elevated levels of high sen-
sitive C-reactive protein, suggestive of an increased risk of
acute coronary events, have been found in
HIV þ individuals with low FRS.4 Markers of subclinical ath-
erosclerosis, such as carotid artery intima-media thickness5,6
and stiffness of femoral artery,7 are altered in asymptomatic
HIV þ individuals, even if antiretroviral-na€ıve.8 At the coro-
nary level, high values of coronary artery calcium (CAC) sug-
gest accelerated coronary ageing in HIV þ patients.9 To
expand the current knowledge on subclinical coronary artery
disease (CAD) inHIVþ subjects,weperformedapilot study in
a group of HIV þ asymptomatic individuals with low cardio-
vascular (CV) risk and a negative echocardiographic and
ECG stress-test. Dual-source CT (MDCT) coronary angiogra-
phy scan10,11 was used as a non-invasive test.
Materials and methods
Patients and methods
HIV-infected subjects recruited from the Department of
Public Health and Infectious Diseases of the “Sapienza”
University of Rome (Italy) were included in this cross-
sectional study. The protocol was approved by the Ethics
Committee of “Azienda Policlinico”, Rome, and all the
patients gave their informed consent to participate. Re-
cruiting method was based on physician referrals and
inclusion/exclusion criteria that were chosen to select
a sample of the asymptomatic HIV infected population
that had a low cardiovascular risk (see below). Multiple
cardiovascular risk factor assessment was utilized for re-
ducing the possibility of selection bias. The size of sample
was determined by the availability of eligible patients
consenting to participate.
The following criteria were needed for inclusion: FR risk
score 10%, absence of metabolic syndrome (according to
the definition of Adult Treatment Panel III e ATPIII12), neg-
ative echocardiographic and ECG stress-test. In addition,
since HIV/HCV coinfection has been associated with an in-
creased risk of cardiovascular disease, patients had to be
negative for anti-HCV antibodies.13
Age, medical and family history, smoking, recreational
drug use, duration of HIV disease (time from diagnosis),
antiretroviral therapies, nadir of CD4þ cell count were
collected. Body mass index (BMI) was calculated for each
subject as weight divided by the square of height.Serum glucose, cholesterol, triglycerides and HDL cho-
lesterol were measured in blood samples. LDL was calcu-
lated according the Friedewald equation.
Current CD4þ and CD8þ cell count were determined by
flow cytometric analysis. HIV-1 RNA plasma levels were
measured by a quantitative reverse polymerase chain
reaction (Amplicor HIV Monitor; Roche Diagnostic Systems,
Branchburg, NJ version 1.5, l.o.d. 50 copies/ml). High
sensitive C-reactive protein (hs-CRP) was measured using
an Instant ELISA kit (Bender MedSystem, Inc Vienna,
Austria) with l.o.d. 78 pg/ml. Cut-off values based on
HIV-uninfected-populations were used to define 3 cate-
gories of cardiovascular risk: < 1 mg/L: low risk; 1e3 mg/L:
average risk: >3 mg/L: high risk.14 As an internal control,
serum hs-CRP was measured in 10 healthy uninfected con-
trols (blood donors); mean value was 0.245  0.319 mg/L.
Stress-test evaluation
Stress echocardiography and ECG were performed in all
patients according to Guidelines.15,16
Multi-detector computed tomography protocol
All patients were examined by using a low-dose prospec-
tively ECG-triggered CT coronary angiography protocol with
a 64-slice multi-detector MDCT scanner (Somatom Defini-
tion Siemens Medical Solution, Forehheimen, Germany). In
patients with heart rates >70 bpm, a single oral dose of a b-
blocker (metoprolol 5 mg) was administered 1 h prior to the
examination.
A preliminary unenhanced acquisition was performed for
determination of coronary calcium score, followed by
a contrast enhanced scan with 70 mL of high concentration
iodine contrast agent (400 mgI/100 mL, Iomeron 400,
Bracco, Milan, Italy) þ40 mL of saline administered in the
antecubital vein.
Calcium score was quantified using the Agatston Calcium
Score method17 from 3 mm non-overlapping sections by us-
ing a semi-automated software (Calcium Scoring CT; Sie-
mens Medical Solutions).
Image analysis
MDCT dataset were transferred and analyzed on a dedicated
cardiac workstation (Vitrea 2.6; Vital Images; USA).
For the analysis, the American Heart Association (AHA)
coronary arteries segmentation model was adopted18,19 and
all segments with a diameter 1 mm at their origin were in-
cluded. Two experienced cardiovascular radiologists (MF and
AA) independently evaluated all coronary segments for the
presence or absence of coronary plaques. Degree of luminal
stenosis was classified as mild (grade I; 30e49%) moderate
84 G. d’Ettorre et al.(grade II; 50e69%), severe (grade III; 70e99%) or coronary oc-
clusion (grade IV; 100%). A threshold of 50% luminal narrowing
in any coronary segment greater than 1.5mm in diameter was
adopted to define clinically significant coronary stenosis.20
According to their CT attenuation values (Hounsfield
Units; HU), significant lesions were semi-quantitatively
classified as follows: non-calcified lesions (density <30
HU), fibro-calcified lesions (31e220 HU) and predominantly
calcified lesions (>221 HU).21,22
Coronary angiography (CA)
All patients with coronary lesions  Grade II at MDCT were
considered for CA. This was performed using standard
technique, with angiograms evaluated by two experienced
readers (MM and FF) blinded to the MDCT results. The AHA
segmentation model23 was applied and degree of stenosis
was quantified (quantitative coronary angiography,QCA) (Al-
lura Xper FD 10, Philips Medical Systems). A significant steno-
siswasdefinedasa reduction indiameter70%.Thedecision
to perform coronary revascularization was made according
to the recently redefined appropriateness criteria.24
Statistical analysis
Descriptive statistics were used to describe the sample.
Values are given as mean  SD. Presence of significant
coronary lesions was considered as a dichotomized variable
(yes/no). The chi square test was used to compare
categorical variables, and the Student’s test for continuous
variables. Pearson correlation coefficient was used to de-
termine correlations. Logistic regression analysis was used
to perform adjusted analysis for binary outcome of the
presence of plaques. A p-value <0.05 was considered statis-
tically significant for all analyses. All statistical analyses
were performed using the SPSS version 17 software pro-
grams (SPSS Inc., Chicago, Illinois, USA).
Results
Patient characteristics
Fifty-five HIV þ subjects with low CVD risk according to the
above criteria were studied. Their main demographic,
clinical and viroimmunological features are summarized in
Table 1. 85.5% of them were males, mean (SD) age was
47.6  8.7 years, FR score was 4.1  3.0 Six (10.9%) were
HAART na€ıve; the remaining 49 had been on HAART for
9.4  5 years. Of them 74.5% had less than 50 copies/ml
of plasma HIV-1 RNA. Mean CD4þ cell count at study was
493  223 cell/mmc; mean CD4þ nadir was
198.9  126 cell/mmc.
CT coronary angiography
MDCT examination was successfully and safely performed in
all patients.
Significant stenoses (i.e grade IIeIV) were observed in
16/55 patients (29.1%). Of these 16, 9 (56.2%) had 1-vessel,
5 (31.3%) had 2-vessel and 2 (12.5%) had 3-vessel coronarydisease. Considering the main coronary arteries, a signifi-
cant obstruction was present in 28 of 64 examined arteries
(43.8%). In 5 of these (17.9%) a significant stenosis involved
the left main coronary artery (LMCA); in 14 (50.0%) the left
anterior descending artery (LAD); in 7 (25.0%) the circum-
flex coronary artery (Cx); in 2 (7.2%) the right coronary
artery (RCA).
When significant plaques were categorized according to
density, in the 16 patients with 50% stenosis and detect-
able plaques, these were soft in 43.8% of cases, mixed in
37.5% and calcified in the remaining 18.8%. In subjects with
non significant stenosis, these proportions were 52.9%,
35.3% and 11.8%, respectively (p Z 0.811, not significant
between the two groups).
As expected, number and extension of the lesions were
higher in patients with more severe stenosis; multiple
lesions were found in 87.5% of those with 50% stenosis
and in 47.1% of subjects with non significant stenosis
(p Z 0.026) Their mean length was 16.66  8.38 and
6  4.33 mm, respectively (p Z 0.001).
Calcium score
Mean Agatston score in the whole population was
21.25  63.53. This value was 1.39  5.35 in subjects
without significant lesions and 103.200  150 in the group
with significant stenosis (p Z 0.016). Values >100 were
found in 6 of 55 (10.9%) patients, all of them with signifi-
cant stenosis.
On the other hand, significant stenosis (due to soft, non-
calcified plaques) was present in 5/16 patients (31.2%) with
<1 Agatston score.
Agatston score progressively and significantly increased
with patient’s age (r Z 0.538; P Z 0.001).
CA results and patient’s revascularization
At the time this paper is written, 13 of the 16 subjects with
significant stenosis at CT have undergone CA; in 8 of them
(61.5%) significant stenoses were found, The distributions
of single-vessel, 2-vessel and 3-vessel disease were 4/8
(50.0%), 2/8 (25.0%), 2/8 (25.0%) respectively.
Eight patients underwent a percutaneous coronary in-
tervention with application of 16 drug-eluting stents (Bio-
sensors, Biomatrix DES) (average number per patient:
2.0). MDCT and CA findings in an individual patient are
reported in Fig. 1.
High sensitive CRP
Hs-CRP mean value was 0.988  0.842 mg/L, consistent with
a lowCVrisk.However, this valuewas significantlyhigher than
value measured in healthy controls (p < 0.001). No values
>3 mg/L were recorded. Twelve subjects had hs-CRP levels
above 1 mg/L and no significant coronary stenosis. Four of
them had detectable plasma HIV-1 RNA and 3 were CDC stage
C at diagnosis. A statistically significant correlation was seen
between hs-CRP values and severity of the obstruction
(rZ 0.292, pZ 0.038). Mean value was 0.92  0.84 mg/L in
subjects with non significant stenosis and 1.29  0.86 mg/L
in those with 50% stenosis (pZ 0.177).
Table 1 Demographic, clinical and viroimmunological characteristics of the whole population and of subjects with mild and
moderateesevere stenosis. Values are expressed as mean  SD or absolute number (percentage). Statistically significant values
are reported in bold.
All CT grade of coronary stenosis p values
0eI (mild) IIeIV (moderateesevere)
N 55 39 (70.9) 16 (29.1)
Males, n, (%) 47 (85.5) 33 (84.6) 14 (87.5) 1.00
Age (mean þ SD) 47.6 þ 8.7 45.4 þ 7.9 53.2 þ 8.2 0.002
HIV diagnosis (years) 9.5 þ 5.5 8.7 þ 5.3 11.4 þ 5.7 0.101
CD4 nadir (cell/ml) 193 þ 126 197 þ 121 183 þ 140 0.726
Naive n, (%) 6 (10.9) 5 (12.8) 1 (6.3) 0.478
HAART (years)* 9.4 þ 5.0 9.0 þ 5.1 10.2 þ 5.3 0.450
ABC (years)* 1.73 þ 2.5 1.4 þ 2.4 2.5 þ 2.5 0.173
PI (years)* 4.4 þ 3.8 4. 3 þ 3.1 4.6 þ 3.1 0.858
Framingham risk 4.1 þ 3.0 3.2 þ 2.5 6.3 þ 3.3 0.003
BMI 22.2 þ 2.5 22.1 þ 2.6 22.5 þ 2.6 0.631
HIV-RNA (log copies/ml) 2.3 þ 1.1 2.5 þ 1.2 1.8 þ 0.5 0.008
Patients with HIV-RNA <50 copies/ml (%) 74.5 66.7 93.8 0.045
* Antiretroviral-treated patients.
Figure 1 Chronic total occlusion of proximal right coronary artery in a 55-year-old female on HAART for 24 years. Multiplanar
reformatting (MPR) and volume rendering reconstruction show proximal right coronary artery (RCA) occlusion with distal refilling
from circumflex artery (a,b). Selective coronary angiography (SCA) confirms DSCT findings (c,d).
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were compared for all the explored variables (Table 1). Age
(45.4  7.9 versus 53.2  8.2, pZ 0.002), Framingham risk
score (3.2  2.5 versus 6.3  3.3; pZ 0.003) and proportion
of subjects with HIV-1 RNA below 50 copies (66.7% versus
93.8%; p Z 0.045) were significantly higher in those with
significant stenoses, consistently with lower HIV-1 RNA
values in these latter (2.5 versus 1.8 log copies/ml). A sig-
nificant correlation was found between age and grade of le-
sions (p Z 0.010) (Fig. 2). In multivariate regression
analysis, after adjusting for potentially confounding vari-
ables, age remained significantly associated with the pres-
ence of significant luminal narrowing (p Z 0.011).
Discussion
In a recent paper Lo et al. performed coronary CT scan in
young, asymptomatic HIV positive subjects, and found an
increased prevalence of subclinical CAD respect to un-
infected controls.25
In this paper we studied 55 HIV þ individuals with low
cardiovascular risk defined on the basis of FRS and addi-
tional parameters, including a negative exercise echocar-
diographic and ECG test. Using a cut-off value of 50% for
defining significant stenoses, as in most published ar-
ticles,20,26e28 we found significant coronary obstructions
in 29% of subjects. Five subjects with significant stenosis
had low values (<1) of calcium score, due to the non-
calcified nature of their plaques. This observation is of in-
terest since a large number of acute coronary syndromes
are caused by sudden ulceration in non-calcified vulnerable
plaques.
According to the guidelines of the AHA, coronary
angiography was planned in all the 16 patients with
significant stenosis at CT scan, and performed in 13 ofFigure 2 Correlation between age and grade of lesions
(r Z 0.408, p Z 0.002). B grade 0eI patients;C grade IIeIV
patients.them. Eight out of 13 showed hemodinamically significant
stenoses requiring revascularization.
As a validated indicator of cardiovascular risk we
measured hs-CRP4; the results were consistent with a low
cardiovascular risk, as expected on the basis of inclusion
criteria. However, the observed correlation between in-
creasing hs-CRP levels and severity of coronary stenosis sug-
gests that in HIV þ population CAD can be present even
with low hs-CRP values. Comparing the two patient groups
(with/without significant coronary stenosis) for all the ex-
plored variables we found that age was the only factor in-
dependently associated with severity of coronary
obstruction.
MDCT is an accurate tool for non-invasive assessment of
coronary arteries.29,30 Although it is not currently recom-
mended in asymptomatic individuals,31 a debate is ongoing
about its use as a screening tool, mainly due to its.ability to
identify non-calcified, potentially vulnerable, plaques.32
Our findings seem to support this approach in older, asymp-
tomatic HIV þ subjects, and highlight the need for larger,
longitudinal studies, where risks and benefits of heart CT
scan are carefully evaluated. in individuals of different
ages.
We acknowledge the limitations of our study, mainly the
small size of the sample and the cross-sectional design, that
does not provide follow up data. On the other hand, the
strict criteria utilized for defining the low cardiovascular
risk in our population (including negative stress ECG and
echocardiography) may add further value to our
observations.
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